Roberto Encarnacion, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: Carr 152 Km 15 Bo Qbadille, Barranquitas, PR 00794 Phone: 787-947-7574 |
Karla M Diaz Zayas, MD General Practice Medicare: Medicare Enrolled Practice Location: Bo. Palo Hincado, Carr. 156, Km 11.6, Int, Barranquitas, PR 00794 Phone: 714-745-9862 |
Dr. Fe Iris Fernandez Cabrera, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: Carr 152 Kil 8.1, Barrio Quebradilla, Barranquitas, PR 00794 Phone: 787-857-0300 Fax: 787-857-0800 |
Juan B Alvarado Rivera, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: C Barcelo, #28, Barranquitas, PR 00794 Phone: 787-857-2688 Fax: 787-857-1730 |
Dr. Mirzia Laboy, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: Carr 152 Interior Barrio Quebrada, Sector Tres Caminos, Barranquitas, PR 00794 Phone: 787-857-1145 Fax: 787-857-1145 |
Rafael Del Campo, M.D. General Practice Medicare: Medicare Enrolled Practice Location: Carr. 152 Km. 1.5, Bo. Quebradillas, Barranquitas, PR 00794 Phone: 787-857-5179 Fax: 787-857-5179 |
Dr. Edgardo R Aponte, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 103 Calle Barcelo, Barranquitas, PR 00794 Phone: 787-857-1987 Fax: 787-857-1987 |
Mr. Oscar Javier Rodriguez, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 156 Calle Barcelo # 53, Barranquitas, PR 00794 Phone: 787-857-2688 Fax: 787-857-1730 |
Dr. Esteban Vazquez Astacio, MD General Practice Medicare: Medicare Enrolled Practice Location: 2073 Calle Cloto, Barranquitas, PR 00794 Phone: 787-857-0300 Fax: 787-857-0800 |
Dr. Lady Marie Berrios Acevedo, MD General Practice Medicare: Medicare Enrolled Practice Location: Carr 152 Km 8.0, Barranquitas, PR 00794 Phone: 787-857-0510 |
Dr. Juan Isidro Guerrero, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: D10 Calle Jazmin, Hc3 Box 7586, Barranquitas, PR 00794 Phone: 787-376-9443 Fax: 787-875-4904 |
Dr. Anibal Jose Ortiz Rivera, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: Carr 152 Km 8.0, Bo Quebradilla, Barranquitas, PR 00794 Phone: 787-857-0300 |
News Archive
Recent research from the Long Life Family Study (LLFS) confirms that severe mortality-associated diseases are less prevalent in the families of long-lived individuals than in the general population. The Journals of Gerontology, Series A will publish these findings in the article titled, "Are Members of Long-Lived Families Healthier than Their Equally Long-Lived Peers? Evidence from the Long Life Family Study" on March 5, 2015.
Our bodies have ten times the amount of microbes than human cells. This set of bacteria is called microbiota. In some instances, bacteria known as pathogens can cause infectious diseases. However, these micro-organisms can also protect us from certain diseases. Researchers from Inserm, Paris Descartes University and the CNRS (French National Centre for Scientific Research), through collaboration with teams from China and Sweden, have recently shown how microbiota protects against the development of type 1 diabetes.
The GSMA today published research that demonstrates the significant socio-economic impact that mHealth adoption will have in Europe. Findings reveal that mHealth could save almost €100 billion in healthcare costs in the EU by 2017 as well as add €93 billion in GDP.
Blue Spoon Consulting Group, LLC, today updated its briefing note examining the degrading trends in pharmaceutical marketing, and what can be done about it. Available for download through the Blue Spoon Consulting website (www.bluespoonconsulting.com), ‘Pharmaceutical Promotion At Its Productivity Frontier' is currently the only piece of strategic writing that looks at a total context of change shaping how pharmaceutical companies market and measure performance.
Adverse events of long term medication with NSAIDs and particularly coxibs, has recently received much attention in the Vioxx matter. Consequently, Vioxx has been withdrawn and Prexige has been withheld from the market. The whole group of coxibs, are now under special observation by drug agencies in both Europe and the United States.
› Verified 9 days ago